EJF Capital »

Keros Therapeutics shares owned by EJF Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by EJF Capital from 13F filings

Historical chart of EJF Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by EJF Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by EJF Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $305k 15k 20.36

More positions owned by EJF Capital

Coastalsouth Bancshares Com New (COSO)
Neptune Ins Hldgs Cl A (NP)
First Ctzns Bancshares Inc D Cl A (FCNCA)
WesBan (WSBC)
First Fndtn (FFWM)
Capital One Financial (COF)
Genworth Finl Com Shs (GNW)
Simmons 1st Natl Corp Cl A $1 Par (SFNC)
Valley National Ban (VLY)
Banc Of California (BANC)
Commercial Bancgroup (CBK)
Berkshire Hills Ban (BBT)
Bridgewater Bancshares (BWB)
Northpointe Bancshares Com Shs (NPB)
First Horizon National Corporation (FHN)

View all positions for EJF Capital

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
State Street Corporation
Alkeon Capital Management
Madison Avenue Partners
OrbiMed Advisors
Qube Research & Technologies
Jacobs Levy Equity Management
Federated Investors
Geode Capital Management
Nantahala Capital Management
Renaissance Technologies
Goldman Sachs Group

View all funds holding Keros Therapeutics